Panacea Venture Healthcare Fund II, L.P. 13D and 13G filings for Amylyx Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:30 pm Sale | 2024-12-31 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | Panacea Venture Healthcare Fund II, L.P. | 2,200,000 2.600% | -2,000,000 (-47.62%) | Filing |
| 2024-03-11 08:44 am Purchase | 2024-03-08 | 13G | Amylyx Pharmaceuticals, Inc. AMLX | Panacea Venture Healthcare Fund II, L.P. | 4,200,000 6.200% | 4,200,000 (New Position) | Filing |